RecruitingNCT07203768

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

Unmasking Polycythemia Vera in Long-Standing Essential Thrombocythemia: A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

Sponsor

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Enrollment

678 participants

Start Date

Dec 1, 2025

Study Type

OBSERVATIONAL

Conditions

Polycythemia Vera Thrombocythemia

Summary

International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with polycythemia vera and thrombocythemia. The study is currently recruiting participants at 24 locations. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(24)

Mayo Clinic

Rochester, Minnesota, United States

University Hospital Halle

Halle, Germany

Hannover Medical School

Hanover, Germany

University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center

Minden, Germany

Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo

Pavia, Lombardy, Italy

Divisione Ematologia, Ospedale San Bortolo

Vicenza, Veneto, Italy

A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia

Alessandria, Italy

ASST Papa Giovanni XXIII, SC Ematologia

Bergamo, Italy

Policlinico S. Orsola - Malpighi

Bologna, Italy

ASST-Spedali Civili

Brescia, Italy

AOU Careggi, Divisione di Ematologia

Florence, Italy

ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia

Milan, Italy

Fondazione IRCCS Cà Grande - Op. Maggiore Policlinico

Milan, Italy

Ospedale San Raffaele

Milan, Italy

ASST MONZA Ospedale San Gerardo Clinica Ematologica

Monza, Italy

Azienda Ospedaliera Universitaria Federico II di Napoli Divisione di Ematologia e Trapianti del Midollo

Naples, Italy

Azienda Ospedaliero Universitaria Maggiore della Carità di Novara SCDU Ematologia

Novara, Italy

Presidio Ospedaliero di Pescara

Pescara, Italy

Fondazione Policlinico Universitario Gemelli

Roma, Italy

Umberto I Policlinico

Roma, Italy

Azienda Ospedaliera Universitaria Integrata - Ospedale Borgo Roma, Unità di Ematologia

Verona, Italy

IDIBAPS, Hospital clinic

Barcelona, Spain

12 Octubre University Hospital

Madrid, Spain

Guy's and St. Thomas' NHS Foundation Trust

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07203768

Related Trials

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

NCT0650608437 locations

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

NCT074292666 locations

CINC424A2X01B Rollover Protocol

NCT02386800101 locations

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

NCT0666191531 locations

MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera

NCT0411650247 locations